financetom
Business
financetom
/
Business
/
Cassava to discontinue development of Alzheimer's disease drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cassava to discontinue development of Alzheimer's disease drug
Mar 25, 2025 5:35 AM

March 25 (Reuters) - Cassava Sciences ( SAVA ) said on

Tuesday it will discontinue the development of its drug for

Alzheimer's disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved